Found: 11
Select item for more details and to access through your institution.
Safety, tolerability and efficacy of lecozotan SR in patients with mild-to-moderate Alzheimer's disease used as monotherapy or adjunctively with a cholinesterase inhibitor
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Safety, tolerability, and preliminary efficacy of SAM-531, a 5HT-6 antagonist, in subjects with mild-to-moderate Alzheimer's disease: Results from a phase 2a study
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Pharmacokinetics and pharmacodynamics of bapineuzumab following multiple intravenous infusions in patients with mild-to-moderate Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P4-366: GSI-953, a potent and selective gamma-secretase inhibitor: Modulation of beta-amyloid peptides and plasma and cerebrospinal fluid pharmacokinetic/pharmacodynamic relationships in humans
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P3-460: Safety, tolerability and pharmacokinetics of multiple doses of lecozotan in patients with Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P3-460: Safety, tolerability and pharmacokinetics of multiple doses of lecozotan in patients with Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 3, p. 299, doi. 10.1111/j.1365-2125.2008.03348.x
- By:
- Publication type:
- Article
Confirmatory population pharmacokinetic analysis for bapineuzumab phase 3 studies in patients with mild to moderate Alzheimer's disease.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 2, p. 221, doi. 10.1002/jcph.393
- By:
- Publication type:
- Article
Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 505, doi. 10.1002/jcph.1980
- By:
- Publication type:
- Article
Novel Application of the Two‐Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of Ertugliflozin.
- Published in:
- CTS: Clinical & Translational Science, 2018, v. 11, n. 4, p. 405, doi. 10.1111/cts.12549
- By:
- Publication type:
- Article
Safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of marstacimab in Chinese participants with severe haemophilia.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1155, doi. 10.1111/hae.14814
- By:
- Publication type:
- Article